JUTOY yields 12.09% · JNJ yields 2.13%● Live data
📍 JUTOY pulled ahead of the other in Year 1
Combined, JUTOY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JUTOY + JNJ for your $10,000?
Jutal Offshore Oil Services Limited, an investment holding company, engages in the fabrication of facilities and provision of integrated services for oil and gas industries, new energy, and refining and chemical industries. The company engages in the construction of large-scale module, offshore engineering, and new energy equipment; project processing design, material procurement, structural prefabrication, machining, painting, assembly, mechanical equipment installation, pre-commissioning and loading, and transportation; painting, electrical installation and commissioning, hull closure and offshore platform construction, transformation, maintenance, and other integrated services; hazardous waste collection, storage, utilization and disposal services for petrochina; energy equipment construction services; and other business services. It operates in the People's Republic of China, the United States, Switzerland, Norway, Singapore, Japan, France, the United Kingdom, the Netherlands, and internationally. Jutal Offshore Oil Services Limited was founded in 1995 and is headquartered in Shenzhen, the People's Republic of China.
Full JUTOY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.